International pricing and distribution of therapeutic pharmaceuticals: An ethical minefield
Business Ethics 14 (2):127–141 (2005)
| Abstract | This article has no associated abstract. (fix it) | |||||||||
| Keywords | No keywords specified (fix it) | |||||||||
| Categories | ||||||||||
| Options |
|
|||||||||
Download options| PhilPapers Archive |
Upload a copy of this paper Check publisher's policy on self-archival Papers currently archived: 5,709 |
| External links |
 |
| Through your library | Configure |
Similar books and articlesFranklin G. Miller & Steven Joffe (2006). Evaluating the Therapeutic Misconception. Kennedy Institute of Ethics Journal 16 (4):353-366.
Robert W. Armstrong (1992). An Empirical Investigation of International Marketing Ethics: Problems Encountered by Australian Firms. Journal of Business Ethics 11 (3):161 - 171.
Diana C. Robertson (1999). Fairness of Pricing Decisions. Business Ethics Quarterly 9 (2):225-243.
Laura Calkins (2010). Detained and Drugged: A Brief Overview of the Use of Pharmaceuticals for the Interrogation of Suspects, Prisoners, Patients, and Pows in the Us. Bioethics 24 (1):27-34.
Gan Shaoping (2007). Human Cloning: An Impassable Ethical Minefield. Contemporary Chinese Thought 39 (2):78-90.
Derek Hill & Caroline Jones (eds.) (2003). Forms of Ethical Thinking in Therapeutic Practice. Open University Press.
Messaoud Mehafdi (2000). The Ethics of International Transfer Pricing. Journal of Business Ethics 28 (4):365 - 381.
Richard A. Spinello (1992). Ethics, Pricing and the Pharmaceutical Industry. Journal of Business Ethics 11 (8):617 - 626.
Patrick Primeaux & John Stieber (1999). When MR = MC: Ethical Efficiencies in Valuing and Pricing. Journal of Business Ethics 18 (2):201 - 211.
Analytics
Monthly downloads
Sorry, there are not enough data points to plot this chart.
|
Added to index2009-01-28Total downloads5 ( #160,518 of 549,715 )Recent downloads (6 months)0How can I increase my downloads? |
My notes
Discussion
